1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Lilly(Eli) & Co Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
862.86 18.36 (2.17%)
38.33% Gain from 52W Low
5.0M
XNYS Volume

XNYS 31 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Dividend
Lilly(Eli) & Co has an upcoming dividend of $1.50 per share due on 14 Nov 2025 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Expensive Valuation
1.0 / 100
Momentum Score
Technically Neutral
58.0 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
919
1Yr Price target upside is 7%
27 analysts

24

S

5

W

1

O

2

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..